顶部联系方式
Have Any Questions? Info@mabspacebio.com
0512-86861701

语言切换

ABOUT
Company Overview
- Categories:About
- Time of issue:2018-01-24 00:00:00
- Views:0
MabSpace Biosciences, is a biotech company focused on discovery and development of innovative antibody based therapeutics for cancer and fibrotic diseases. It was founded in 2013 by indrustrial veterans and is located in Biobay Suzhou, an emerging bitech incubator in China. MabSpace employes its proprietary platform technology, immune tolerance breaking technology (IMBT), to generate lead antibodies with diverse epitopes. MabSpace has established multiple antibody discovery and co-development partnerships based on this technology. MabSpace raised 15 million USD from Lilly Asia Ventures in 2015 to advance its lead antibody program, a potentially best-in-class anti-PD-L1 antibody with unique pH-dependent binding and recycling property and significantly improved efficacy in animal models. It has also built a panel of 2nd generation immuno-oncology antibodies targeting different components of the tumor microenvironment,which enables the testing of combination therapeutic interventions with its PD-L1 antibody.
Scan the QR code to read on your phone
页脚关于我们
页脚管道
页脚新闻
页脚人力资源
页脚联系方式
页脚版权
Copyright © 2019 Mabspace Biosciences All rights reserved